Posted on

American Regent researches, develops and commercializes sterile pharmaceutical drug products for the U.S. and global markets. The company is capable of manufacturing a full range of pharmaceutical products including injectables, ophthalmics, otics, nasals, simple solutions and suspensions, oncolytics, highly potent compounds, biologics and large molecules. American Regent develops drug products across a wide therapeutic range including vasodilators, anti-arrhythmic agents, CNS agents, anti-infectives, immuno-suppressants, antifungals, beta-blockers and antivirals. Developmental capabilities also include active pharmaceutical ingredient qualification, analytical methods development and validation, product stability storage and monitoring, analytical testing and drug product dossier development and submission.